论文部分内容阅读
乙肝六号是本院研制的一种治疗乙型肝炎的口服制剂。实验表明 ,乙肝六号能促进正常肝细胞 DNA和 RNA的合成 ,促进肝细胞修复并增加其功能 ,具有保护肝细胞膜和抑制病毒复制的综合作用。临床经 2 0 0例观察发现 SGPT、TTT复常率和 HBs Ag、HBe Ag半年转阴率分别达 80 %、81%和 2
Hepatitis B VI is an oral preparation for treatment of Hepatitis B developed by the hospital. Experiments have shown that hepatitis B6 can promote the synthesis of DNA and RNA in normal liver cells, promote hepatocyte repair and increase its function, and have a comprehensive role in protecting hepatocyte membrane and inhibiting virus replication. The clinical observation of 200 cases revealed that the SGPT, TTT recurrence rate, and HBsAg and HBeAg half-year negative rate were 80%, 81%, and 2 respectively.